Pfizer

Now, Moderna Says Its Vaccine Is 94.5% Effective in Preventing COVID-19

In Surprise Ruling, FDA Rejects American Co’s Gene Therapy for Haemophilia

There’s a New Outbreak – of Vaccine Nationalism

US to Pay $2.1 Billion to Sanofi, GSK in COVID-19 Vaccine Deal

Your Quick Guide to the Leading COVID-19 Vaccines

COVID-19: New Results Shine Ray of Hope on Vaccine Development Efforts

The changes to the NPPA suggest that the price regulator has been underperforming, when, in fact, it has been sticking close to its government-given mandate. Credit: Reuters

Conflicts of Interest With India’s Health Industry: The Need for Legal Intervention